First-ever clinical trial exclusively conducted among people with hard-to-treat form of tuberculosis known as pre-extensively drug-resistant TB shows many patients benefit from shorter, simpler ...

A vaccine protects more than 100 million infants each year from severe tuberculosis (TB), including the fatal brain swelling it can cause in babies and toddlers.

Recasting resistance to Mycobacterium tuberculosis Why some individuals ‘resist’ infection with Mycobacterium tuberculosis (Mtb) has been an enigma.